相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。RNA Editing of the IQ Domain in Cav1.3 Channels Modulates Their Ca2+-Dependent Inactivation
Hua Huang et al.
NEURON (2012)
RNA editing of protein sequences: A rare event in human transcriptomes
Claudia L. Kleinman et al.
RNA (2012)
RNA Editing Underlies Temperature Adaptation in K+ Channels from Polar Octopuses
Sandra Garrett et al.
SCIENCE (2012)
Comment on Widespread RNA and DNA Sequence Differences in the Human Transcriptome
Claudia L. Kleinman et al.
SCIENCE (2012)
Identification and Characterization of Two Novel RNA Editing Sites in grin1b Transcripts of Embryonic Danio rerio
Pedro Pozo et al.
NEURAL PLASTICITY (2012)
The essential role of AMPA receptor GluA2 subunit RNA editing in the normal and diseased brain
Amanda Wright et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
A-to-I RNA Editing Modulates the Pharmacology of Neuronal Ion Channels and Receptors
A. K. Streit et al.
BIOCHEMISTRY-MOSCOW (2011)
RNA editing of Kv1.1 channels may account for reduced ictogenic potential of 4-aminopyridine in chronic epileptic rats
Anne Kathrin Streit et al.
EPILEPSIA (2011)
Calcium Channel Blockers
William J. Elliott et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Benzodiazepines for prolonged seizures
Mark Anderson
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2010)
RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels
Niels Decher et al.
EMBO JOURNAL (2010)
The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome
R. Barrons et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Large-scale detection and analysis of RNA editing in grape mtDNA by RNA deep-sequencing
Ernesto Picardi et al.
NUCLEIC ACIDS RESEARCH (2010)
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Srikant Rangaraju et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
RNA editing of the GABAA receptor α3 subunit alters the functional properties of recombinant receptors
Mitchell L. Nimmich et al.
NEUROSCIENCE RESEARCH (2009)
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line
Jun Sawada et al.
NEUROSCIENCE RESEARCH (2009)
Genome-Wide Identification of Human RNA Editing Sites by Parallel DNA Capturing and Sequencing
Jin Billy Li et al.
SCIENCE (2009)
Pharmacotherapy of insomnia
Abid Bhat et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons
Nicholas P. Whitney et al.
FASEB JOURNAL (2008)
Developmental modulation of GABAA receptor function by RNA editing
Elizabeth Y. Rula et al.
JOURNAL OF NEUROSCIENCE (2008)
A conservative, single-amino acid substitution in the second cytoplasmic domain of the human serotonin2C receptor alters both ligand-dependent and -independent receptor signaling
Kelly A. Berg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Calcium, ageing, and neuronal vulnerability in Parkinson's disease
D. James Surmeier
LANCET NEUROLOGY (2007)
Regulation of glutamate receptor B pre-mRNA splicing by RNA editing
Vera K. Schoft et al.
NUCLEIC ACIDS RESEARCH (2007)
Editing modifies the GABAA receptor subunit α3
Johan Ohlson et al.
RNA (2007)
Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials
Jose Luis R. Martin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Rigidity and spasms from autoimmune encephalomyelopathies: Stiff-Person syndrome
Alberto J. Espay et al.
MUSCLE & NERVE (2006)
Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy
Evelyne Beraud et al.
ANNALS OF NEUROLOGY (2006)
Binding site of a novel Kv1.5 blocker: A foot in the door against atrial fibrillation
Niels Decher et al.
MOLECULAR PHARMACOLOGY (2006)
The antiepileptic activity of JSTX-3 is mediated by N-methyl-D-aspartate receptors in human hippocampal neurons
SD Salamoni et al.
NEUROREPORT (2005)
Q/R site editing controls kainate receptor inhibition by membrane fatty acids
TJ Wilding et al.
JOURNAL OF NEUROSCIENCE (2005)
EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force
G Bråthen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
RNA editing produces glycine receptor α3P185L, resulting in high agonist potency
JC Meier et al.
NATURE NEUROSCIENCE (2005)
A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10
DR Clutterbuck et al.
BIOINFORMATICS (2005)
Systematic identification of abundant A-to-I editing sites in the human transcriptome
EY Levanon et al.
NATURE BIOTECHNOLOGY (2004)
Kv1.3-blocking 5-phenylalkoxypsoralens:: A new class of immunomodulators
J Vennekamp et al.
MOLECULAR PHARMACOLOGY (2004)
Control of human potassium channel inactivation by editing of a small mRNA hairpin
T Bhalla et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia
S Dracheva et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Nervous system targets of RNA editing identified by comparative genomics
B Hoopengardner et al.
SCIENCE (2003)
Coordination of editing and splicing of glutamate receptor pre-mRNA
E Bratt et al.
RNA (2003)
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims
I Gurevich et al.
NEURON (2002)
Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis
C Beeton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
RNA-editing of the 5-HT2C receptor alters agonist-receptor-effector coupling specificity
KA Berg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The glycinergic inhibitory synapse
P Legendre
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)